Operates a biomedical group

The company was built upon the highest morals, ethics and values. Their vision was, and still is, to provide the best products in the fastest lead times at competitive prices. - 30+ years of engineering experience - 10+ years of rapid prototyping experience - David K. Leigh assisted in the development of the Sinterstation® 2000 while at DTM Corporation (now 3D Systems) - Have developed proprietary techniques of post-processing and finishing of rapid prototypes

Shandong Taibang Biological Products Co. Ltd., part of China Biologic Products Holdings, Inc., is a Chinese company located in Tai'an that manufactures and wholesales biological products. The firm was founded in 2002. Guang Li Pang has been the CEO since the company founding.

Takeda Pharmaceutical Company Ltd (武田薬品工業株式会社 Takeda Yakuhin Kōgyō Kabushiki-gaisha) is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 30,000 employees worldwide and achieved 16.2 billion USD in revenue during the 2012 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.

Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France.

SomaLogic operates as a protein biomarker discovery and clinical diagnostics company. It offers SOMAmers (Slow-Offrate Modified Aptamers), which are modified nucleic acid-based protein-binding reagents that are specific for their cognate protein; and SOMAscan that provides protein detection and equipment. The company’s SOMAmer/SOMAscan technology enables to discover protein biomarker signatures; drug discovery and development; and clinical diagnostics. Its products have applications in the diagnostics of various diseases in oncology, neurology, cardiovascular and metabolic disease, and other diseases and conditions. SomaLogic was founded in 1999 and is headquartered in Boulder, Colorado.

The American Red Cross (ARC), also known as the American National Red Cross, is a humanitarian organization that provides emergency assistance, disaster relief, and education inside the United States. It is the designated U.S. affiliate of the International Federation of Red Cross and Red Crescent Societies. It is the largest single supplier of blood and blood products in the United States, collecting and processing approximately 40 percent of the blood supply and distributing it to about 2,600 hospitals and transfusion centers nationwide. The organization researches and tests to protect the safety of the blood supply. It was among the first to develop and implement testing for many infectious diseases including, HIV, hepatitis B and C viruses, West Nile virus, and Chagas disease. The ARC operates the nationwide hemovigilance program to examine donor and patient adverse reactions. Data from the program is used to enhance blood product quality and safety The ARC serves on key committees of AABB and other blood-related organizations, and works closely with the U.S. Food and Drug Administration (FDA). The American Red Cross was established in 1881 and is headquartered in Washington, District of Columbia with 39 immunohematology reference laboratories nationwide.

Hunan Phenol Biotechnology Co., Ltd., established on 2021-03-09, Business scope includes biotechnology development services,consult,communication service,transfer service;Plant extracts,Research and development of biological products;research and development,Incubation and Transformation;Sales of biological reagents,research and development;Retail of organic fertilizers and microbial fertilizers;fertilizer,Microbial fertilizer,microbial soil,Water quality restoration product technology development,Technical Services,Sales;Biopharmaceutical Technology Development;Biopharmaceutical technology transfer;Feed Additives Wholesale;concentrated feed,compound feed,feed ingredients,Medical Laboratory Equipment and Appliances,Laboratory Consumables Sales;feed retail;Production of plant extracts(limited branch);Production of Chinese herbal extracts(limited branch).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Do not engage in unauthorizedP2Ponline loan,Equity crowdfunding,internet insurance,Asset management and cross-border finance,Third party payment,virtual currency transaction,ICO,Internet financial services such as illegal foreign exchange)

Hebei Kangteng Biotechnology Co., Ltd., established on 2017-09-13, Business scope includes bioengineering technology research and development,Biotechnology Extension Services,technical consulting,Health Consulting Services(Does not include diagnosis and treatment),Business Management Consulting Services,Conference and Exhibition Services,marketing planning,Genetic Testing,Medical device research and development,Educational Consulting(without training);medical instruments,household appliances,electronic product,Clothing and shoes,cosmetic,daily necessities,drug sales;software development,technology development,Technical Services,technology transfer;Clinic Services(Limited to branch operations)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)***

Baxalta GmbH, a subsidiary of Takeda Pharmaceutical Co., Ltd., is a Swiss company located in Glattpark that manufactures and wholesales pharmaceutical products. It was founded in 2000. Julie So-Young Kim is currently the CEO of the firm.

Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL.

China Resources Boya Bio-pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of blood products. It operates through the following business segments: Blood Products, Diabetes Medication, and Biochemical drugs. The Blood Products segment includes products such as albumin, immunoglobulin, and blood clotting factors. The Diabetes Medication segment includes metformin hydrochloride tablets, enteric-coated tablets, and calcium hydroxybenzenesulfonate capsules. The Biochemical Drugs segment includes medication such as compound bone peptide injections, oxytocin injections, and heparin sodium injections. The company was founded on November 6, 1993 and is headquartered in Fuzhou, China.

Tianjin Medical University General Hospital (Chinese: 天津医科大学总医院) is a general hospital in the central Heping District of the Chinese metropolis of Tianjin, associated with Tianjin Medical University.

Part of Global Cord Blood Corp., Guangzhou Municipality Tianhe Nuoya Bio-engineering Co., Ltd. (doing business as Tianhe Nuoya Bio-engineering Co., Ltd.) is a company headquartered in Guangzhou, China, that provides cord blood banking services.